HCM
IBB icon

Horan Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Horan Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-4,506
Closed -$440K – 74
2017
Q1 		$440K Buy
+4,506
New +$431K 0.1% 65

Other funds holding IBB

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Horan Capital Management's IBB Position: Q2 2017 in Review

Horan Capital Management sold out of iShares Biotechnology ETF (IBB) in Q2 2017, closing a stake of 4,506 shares — an estimated $440K sold.

Horan Capital Management first reported a position in IBB in Q1 2017 and held it in 1 quarter. The position peaked at $440K in Q1 2017. 561 funds tracked by Wall St. Rank hold IBB as of Q2 2017.

  • Horan Capital Management reported no remaining iShares Biotechnology ETF position as of Q2 2017 after selling out during the quarter.
  • Horan Capital Management sold 4,506 iShares Biotechnology ETF shares in Q2 2017, an estimated $440K.
  • Horan Capital Management first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 1 quarter.
  • Horan Capital Management's iShares Biotechnology ETF position peaked at $440K in Q1 2017.
  • 561 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2017.

Based on Horan Capital Management's 13F filing for Q2 2017, filed 17 Jul 2017.